EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Failed cellular surveillance enables pathogenic matrix deposition in a COL2A1-related osteoarthritis

Kathryn M Yammine, Sophia Mirda Abularach, Michael Xiong, Seo-Yeon Kim, Agata A Bikovtseva, Vincent L Butty, Richard P Schiavoni, John F Bateman, Shireen R Lamandé, Matthew D Shoulders

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Kathryn M Yammine und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States. Hauptthemen laut MEDLINE: Collagen Type II, Osteoarthritis, Extracellular Matrix. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NCI NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the COL2A1 gene, encoding procollagen-II, cause various chondrodysplasias, including precocious osteoarthritis with mild spondyloepiphyseal dysplasia engendered by the p.Arg719Cys substitution. The molecular mechanisms underlying these disorders remain incompletely understood, largely owing to the absence of models faithfully recapitulating the human disease. Here, we developed an in vitro human cartilage model using isogenic induced pluripotent stem cell (iPSC) lines carrying either wild-type or Arg719Cys COL2A1. Directed differentiation into chondrocytes yielded cartilage tissues that were analyzed by immunohistochemistry, electron microscopy, SDS-PAGE, and RNA-sequencing. Tissues derived from Arg719Cys heterozygotes displayed a deficient matrix, closely reflecting the human disease phenotype. Arg719Cys procollagen-II was excessively post-translationally modified and partially retained within the endoplasmic reticulum (ER), leading to ER distention. Notably, despite introduction of an aberrant cysteine residue-expected to engage redox-sensitive folding and quality control pathways-Arg719Cys procollagen-II was not detectably recognized by the ER proteostasis network. The resulting inability to mount a quality control response, including absent activation of the unfolded protein response, indicates a failure in cellular surveillance. As a result, malformed procollagen-II both accumulates intracellularly and is secreted, contributing to the deposition of a structurally compromised extracellular matrix that drives disease pathology. The iPSC-derived cartilage model presented here provides a genetically defined, expandable, and human-based system for dissecting mechanisms of failed proteostasis in collagenopathies. These findings shed light on the types of substitutions in procollagen that cells do or do not recognize, and underscore the therapeutic potential of targeting cellular surveillance and collagen quality control pathways in COL2A1-related disorders and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IIOsteoarthritisExtracellular MatrixHumansChondrocytesInduced Pluripotent Stem CellsEndoplasmic ReticulumOsteochondrodysplasiasCell Differentiation

Stichwörter der Autor:innen

cartilagecollagenendoplasmic reticulum stressextracellular matrixiPSC-based disease modelprecocious osteoarthritisprotein foldingproteostasisunfolded protein response

Substanzen

COL2A1 protein, humanCollagen Type II

Autor:innen und Institutionen

  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States.
  • BioMicro Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States.
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States.
  • Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
  • Murdoch Children's Research Institute, Parkville, Victoria, Australia; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW…
  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, U…

Förderung

  • NIAMS NIH HHS
  • NCI NIH HHS
  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • National Institute of Environmental Health Sciences
  • G. Harold and Leila Y. Mathers Charitable Foundation
  • National Health and Medical Research Council
  • State Government of Victoria

Zitieren

APA

Yammine, K. M., Mirda Abularach, S., Xiong, M., Kim, S. Y., Bikovtseva, A. A., Butty, V. L., Schiavoni, R. P., Bateman, J. F., Lamandé, S. R., & Shoulders, M. D. (2025). Failed cellular surveillance enables pathogenic matrix deposition in a COL2A1-related osteoarthritis. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110436

Vancouver

Yammine KM, Mirda Abularach S, Xiong M, Kim SY, Bikovtseva AA, Butty VL, et al. Failed cellular surveillance enables pathogenic matrix deposition in a COL2A1-related osteoarthritis. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110436

BibTeX
@article{Yammine2025,
  author = {Yammine, Kathryn M and Mirda Abularach, Sophia and Xiong, Michael and Kim, Seo-Yeon and Bikovtseva, Agata A and Butty, Vincent L and Schiavoni, Richard P and Bateman, John F and Lamandé, Shireen R and Shoulders, Matthew D},
  title = {Failed cellular surveillance enables pathogenic matrix deposition in a COL2A1-related osteoarthritis},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110436}
}
Kostenlos starten →